ArticleCancer letters2011

Constitutively active Harvey Ras confers resistance to epidermal growth factor receptor-targeted therapy with cetuximab and gefitinib.

Rodney B Luwor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.